BIODESIX, INC. Provision for Loan, Lease, and Other Losses
BIODESIX, INC. (BDSX) reported Provision for Loan, Lease, and Other Losses of $116.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForLoanLeaseAndOtherLosses · last filed 2026-08-05
- BIODESIX, INC. provision for loan, lease, and other losses for the quarter ending 2026-06-30 was $92.00K, a 1050.00% increase year-over-year.
- BIODESIX, INC. provision for loan, lease, and other losses for the quarter ending 2026-03-31 was $24.00K, a 76.24% decline year-over-year.
- BIODESIX, INC. provision for loan, lease, and other losses for the quarter ending 2025-12-31 was $71.00K, a 83.64% decline year-over-year.
- BIODESIX, INC. provision for loan, lease, and other losses for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- BIODESIX, INC. provision for loan, lease, and other losses for fiscal 2025 was $180.00K, a 79.71% decline from fiscal 2024.
- BIODESIX, INC. provision for loan, lease, and other losses for fiscal 2024 was $887.00K, a 78.47% increase from fiscal 2023.
- BIODESIX, INC. provision for loan, lease, and other losses for fiscal 2023 was $497.00K.
| Period end | Provision for Loan, Lease, and Other Losses 3 month | Provision for Loan, Lease, and Other Losses 6 month | Provision for Loan, Lease, and Other Losses 9 month | Provision for Loan, Lease, and Other Losses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $116.00K 10-Q · filed 2026-08-05 | $187.00K derived: sum of 3 quarters · filed 2026-08-05 | $187.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $24.00K 10-Q · filed 2026-05-04 | $95.00K derived: sum of 2 quarters · filed 2026-05-04 | $95.00K derived: sum of 3 quarters · filed 2026-05-04 | $103.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $71.00K derived: sum of 2 quarters · filed 2026-02-26 | $79.00K derived: sum of 3 quarters · filed 2026-08-05 | $180.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $8.00K derived: sum of 2 quarters · filed 2026-08-05 | $109.00K 10-Q · filed 2025-11-03 | $543.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $109.00K 10-Q · filed 2026-08-05 | $543.00K derived: sum of 3 quarters · filed 2026-08-05 | $776.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $101.00K 10-Q · filed 2026-05-04 | $535.00K derived: sum of 2 quarters · filed 2026-05-04 | $768.00K derived: sum of 3 quarters · filed 2026-05-04 | $859.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $434.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $667.00K derived: sum of 2 quarters · filed 2026-02-26 | $758.00K derived: sum of 3 quarters · filed 2026-02-26 | $887.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $324.00K derived: sum of 2 quarters · filed 2025-11-03 | $453.00K 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $220.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $129.00K 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $497.00K 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |